Featuring a slide presentation and related discussion from Dr Matthew Lunning, including the following topics:
- Overview of available chimeric antigen receptor (CAR) T-cell therapies (0:00)
- Toxicities associated with CAR T-cell therapy (4:03)
- Mitigation strategies for adverse events (22:02)
- Novel strategies for outpatient infusion (26:34)
- Changes to the CAR T-cell therapy safety regulations (30:23)